Armistice Capital »

Repligen Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Repligen Corporation (RGEN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Repligen Corporation

Tip: Access up to 7 years of quarterly data

All positions including Repligen Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repligen Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $316k 2.4k 133.67

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Repligen Corporation

BlackRock
Vanguard Group
United Capital Financial Advisers
FMR
State Street Corporation
Citadel Advisors
Point72 Asset Management
Holocene Advisors
Champlain Investment Partners
Bank of New York Mellon
Alliancebernstein
Geode Capital Management
Conestoga Capital Advisors
Millennium Management
Invesco

View all funds holding Repligen Corporation